Novel Targeted Therapies for Inflammatory Bowel Disease
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference102 articles.
1. Ulcerative colitis;Ordas;Lancet,2012
2. Crohn's disease;Baumgart;Lancet,2012
3. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review;Molodecky;Gastroenterology,2012
4. Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study;Hoivik;Gut,2013
5. The burden of inflammatory bowel disease in Europe;Burisch;J. Crohns. Colitis,2013
Cited by 143 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Integrative analysis revealed novel putative therapeutic targets of ulcerative colitis: Role of creatine;International Immunopharmacology;2024-12
2. Loss of DOCK2 potentiates Inflammatory Bowel Disease–associated colorectal cancer via immune dysfunction and IFNγ induction of IDO1 expression;Oncogene;2024-09-07
3. ITGB2 related to immune cell infiltration as a potential therapeutic target of inflammatory bowel disease using bioinformatics and functional research;Journal of Cellular and Molecular Medicine;2024-08
4. Involvement of PD-1+CD4+ T cells in the development of traumatic tracheal stenosis by regulating the IL-17/STAT3 pathway;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-08
5. A novel synbiotic protects against DSS-induced colitis in mice via anti-inflammatory and microbiota-balancing properties;2024-07-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3